1. Home
  2. HELE vs IMMP Comparison

HELE vs IMMP Comparison

Compare HELE & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helen of Troy Limited

HELE

Helen of Troy Limited

HOLD

Current Price

$17.02

Market Cap

436.1M

ML Signal

HOLD

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$2.75

Market Cap

426.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HELE
IMMP
Founded
1968
1987
Country
United States
Australia
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
436.1M
426.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HELE
IMMP
Price
$17.02
$2.75
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$22.00
N/A
AVG Volume (30 Days)
788.3K
182.1K
Earning Date
01-08-2026
02-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,802,156,000.00
$3,306,742.00
Revenue This Year
N/A
$292.48
Revenue Next Year
$0.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
31.28
52 Week Low
$16.29
$1.32
52 Week High
$60.42
$3.53

Technical Indicators

Market Signals
Indicator
HELE
IMMP
Relative Strength Index (RSI) 38.72 46.93
Support Level $17.95 $2.56
Resistance Level $19.44 $2.83
Average True Range (ATR) 0.99 0.14
MACD 0.04 -0.03
Stochastic Oscillator 21.27 28.36

Price Performance

Historical Comparison
HELE
IMMP

About HELE Helen of Troy Limited

Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.

About IMMP Immutep Limited

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: